Lexeo Therapeutics, Inc. Common Stock (LXEO) earnings · rev $654.0K
These earnings events as JSON? API free 100/dayLexeo Therapeutics, Inc. Common Stock (LXEO) is a biotechnology company listed on US.
This LXEO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported LXEO revenue for 2022-12-31 was $654.0K. Net income was $59.3M. LXEO currently screens at market cap $147.7M.
When the next LXEO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for LXEO. We will not invent a beat or miss.
Not investment advice. Full LXEO research stays on the stock page; the tape stays on the quote page.
LXEO earnings FAQ
What are LXEO's latest revenue and net income?
Latest cached Lexeo Therapeutics, Inc. Common Stock (LXEO) revenue for Dec 31, 2022 was $654.0K. Net income was $59.3M. Statements: https://lician.com/financials/lxeo
What period does the latest LXEO earnings print cover?
The latest cached Lexeo Therapeutics, Inc. Common Stock (LXEO) earnings print covers Dec 31, 2022.
Where are LXEO earnings listed?
Cached earnings facts for Lexeo Therapeutics, Inc. Common Stock (LXEO) are listed at https://lician.com/earnings/lxeo. Statements: https://lician.com/financials/lxeo
Not investment advice.